These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9391305

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Clinical significance of antinuclear antibodies: comparison of detection with immunofluorescence and enzyme-linked immunosorbent assays.
    Emlen W, O'Neill L.
    Arthritis Rheum; 1997 Sep; 40(9):1612-8. PubMed ID: 9324015
    [Abstract] [Full Text] [Related]

  • 44. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease.
    Meliconi R, Bestagno M, Sturani C, Negri C, Galavotti V, Sala C, Facchini A, Ciarrocchi G, Gasbarrini G, Astaldi Ricotti GC.
    Clin Exp Immunol; 1989 May; 76(2):184-9. PubMed ID: 2547538
    [Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
    Salazar-Páramo M, Jara LJ, Ramos A, Barile L, Machado G, García-De La Torre I.
    Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
    [Abstract] [Full Text] [Related]

  • 48. Association between antinuclear antibody titers and connective tissue diseases in a Rheumatology Department.
    Menor Almagro R, Rodríguez Gutiérrez JF, Martín-Martínez MA, Rodríguez Valls MJ, Aranda Valera C, de la Iglesia Salgado JL.
    Reumatol Clin; 2017 Aug; 13(3):150-155. PubMed ID: 27221374
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Simultaneous identification of various antinuclear antibodies using an automated multiparameter line immunoassay system.
    López-Longo FJ, Rodríguez-Mahou M, Escalona-Monge M, González CM, Monteagudo I, Carreño-Pérez L.
    Lupus; 2003 Aug; 12(8):623-9. PubMed ID: 12945722
    [Abstract] [Full Text] [Related]

  • 51. Relevance of complement fixing antinuclear antibodies.
    Fang YV, Cyran SJ, Albini B, Rostami R, Binder WL, Beutner EH.
    Int J Dermatol; 1999 Feb; 38(2):96-100. PubMed ID: 10192156
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Antibodies to dsDNA in connective tissue diseases measured by ultramicro enzyme-linked immunosorbent assay (ELISA) adapted to the chamber analytical technique (CAT).
    Wollina U.
    Arch Dermatol Res; 1984 Feb; 276(3):182-5. PubMed ID: 6383228
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. An enzyme immunoassay screening test for the detection of total antinuclear antibodies.
    Moncé NM, Bogusky RT, Cappel NN.
    J Clin Lab Anal; 1991 Feb; 5(6):439-42. PubMed ID: 1774608
    [Abstract] [Full Text] [Related]

  • 59. Evaluation of anti-ribosomal P protein immunoassay in Japanese patients with connective tissue diseases: comparison with an indirect immunofluorescence assay.
    Muro Y, Sugiura K, Morita Y, Tomita Y.
    Scand J Rheumatol; 2009 Feb; 38(6):460-3. PubMed ID: 19922022
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.